Danaher Net Income Over Time
| DHR Stock | USD 206.50 6.08 2.86% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Danaher Performance and Danaher Correlation. Can Health Care Equipment & Supplies industry sustain growth momentum? Does Danaher have expansion opportunities? Factors like these will boost the valuation of Danaher. Projected growth potential of Danaher fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Danaher demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth 0.125 | Dividend Share 1.28 | Earnings Share 5.04 | Revenue Per Share | Quarterly Revenue Growth 0.046 |
The market value of Danaher is measured differently than its book value, which is the value of Danaher that is recorded on the company's balance sheet. Investors also form their own opinion of Danaher's value that differs from its market value or its book value, called intrinsic value, which is Danaher's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Danaher's market value can be influenced by many factors that don't directly affect Danaher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Danaher's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Danaher should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Danaher's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare Danaher and related stocks such as Boston Scientific Corp, Stryker, and Thermo Fisher Scientific Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BSX | 41.8 M | 441 M | (4.1 B) | (121 M) | (119 M) | (239 M) | 347 M | 104 M | 1.7 B | 4.7 B | (82 M) | 1 B | 698 M | 1.6 B | 1.9 B | 2.9 B | 3 B |
| SYK | 8.4 M | 1.3 B | 1.3 B | 1 B | 515 M | 1.4 B | 1.6 B | 1 B | 3.6 B | 2.1 B | 1.6 B | 2 B | 2.4 B | 3.2 B | 3 B | 3.2 B | 3.4 B |
| TMO | 9.6 M | 1.3 B | 1.2 B | 1.3 B | 1.9 B | 2 B | 2 B | 2.2 B | 2.9 B | 3.7 B | 6.4 B | 7.7 B | 7 B | 6 B | 6.3 B | 6.7 B | 7.1 B |
| GILD | (4 M) | 2.8 B | 2.6 B | 3.1 B | 12.1 B | 18.1 B | 13.5 B | 4.6 B | 5.5 B | 5.4 B | 123 M | 6.2 B | 4.6 B | 5.7 B | 480 M | 8.5 B | 8.9 B |
| AMGN | 500 K | 3.7 B | 4.3 B | 5.1 B | 5.2 B | 6.9 B | 7.7 B | 2 B | 8.4 B | 7.8 B | 7.3 B | 5.9 B | 6.6 B | 6.7 B | 4.1 B | 7.7 B | 8.1 B |
| PFE | 579.7 M | 8.7 B | 9.8 B | 11.6 B | 9.1 B | 7 B | 7.2 B | 21.3 B | 11.2 B | 16.3 B | 9.2 B | 22.1 B | 31.4 B | 2.1 B | 8 B | 7.8 B | 7.8 B |
| MDT | 53.4 M | 3.6 B | 3.5 B | 3.1 B | 2.7 B | 3.5 B | 4 B | 3.1 B | 4.6 B | 4.8 B | 3.6 B | 5 B | 3.8 B | 3.7 B | 4.7 B | 5.4 B | 5.6 B |
| ISRG | (29.4 M) | 495.1 M | 656.6 M | 671 M | 418.8 M | 588.8 M | 735.9 M | 660 M | 1.1 B | 1.4 B | 1.1 B | 1.7 B | 1.3 B | 1.8 B | 2.3 B | 2.9 B | 3 B |
| MCK | 404.5 M | 1.4 B | 1.3 B | 1.3 B | 1.5 B | 2.3 B | 5.2 B | 67 M | 34 M | 900 M | (4.5 B) | 1.1 B | 3.6 B | 3 B | 3.3 B | 3.8 B | 4 B |
| SNY | 625 M | 5.6 B | 4.9 B | 3.7 B | 4.4 B | 4.3 B | 4.7 B | 8.4 B | 4.3 B | 2.8 B | 12.3 B | 6.2 B | 8.4 B | 5.4 B | 5.6 B | 7.8 B | 5 B |
Danaher and related stocks such as Boston Scientific Corp, Stryker, and Thermo Fisher Scientific Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Danaher financial statement analysis. It represents the amount of money remaining after all of Danaher operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Danaher | DHR |
| Classification | Healthcare |
| Business Address | 2200 Pennsylvania Avenue |
| Exchange | New York Stock Exchange |
USD 206.5
Additional Tools for Danaher Stock Analysis
When running Danaher's price analysis, check to measure Danaher's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Danaher is operating at the current time. Most of Danaher's value examination focuses on studying past and present price action to predict the probability of Danaher's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Danaher's price. Additionally, you may evaluate how the addition of Danaher to your portfolios can decrease your overall portfolio volatility.